{
    "root": "31188d23-42f7-40d7-e063-6394a90a1e58",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Prochlorperazine Edisylate",
    "value": "20250324",
    "ingredients": [
        {
            "name": "SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM",
            "code": "3980JIH2SW"
        },
        {
            "name": "SODIUM TARTRATE",
            "code": "QTO9JB4MDD"
        },
        {
            "name": "SACCHARIN SODIUM",
            "code": "SB8ZUX40TY"
        },
        {
            "name": "BENZYL ALCOHOL",
            "code": "LKG8494WBH"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "PROCHLORPERAZINE EDISYLATE",
            "code": "PG20W5VQZS"
        }
    ],
    "indications": "control severe nausea vomiting . treatment schizophrenia . prochlorperazine shown effective management behavioral complications patients mental retardation .",
    "contraindications": "note injection : intramuscular , inject deeply upper , outer quadrant buttock . subcutaneous advisable local irritation .",
    "warningsAndPrecautions": "prochlorperazine edisylate injection , usp 5 mg/ml 2 ml ( 10 mg ) vial , packaged 10 's ( ndc14789-700-02 )",
    "adverseReactions": "patients known hypersensitivity phenothiazines . comatose states presence large amounts central nervous system depressants ( alcohol , barbiturates , narcotics , etc . ) . pediatric surgery . pediatric patients 2 years age 20 lbs . children conditions established .",
    "indications_original": "To control severe nausea and vomiting. For the treatment of schizophrenia.\n                  Prochlorperazine has not been shown effective in the management of behavioral complications in patients with mental retardation.",
    "contraindications_original": "NOTE ON INJECTION:For intramuscular administration, inject deeply into the upper, outer quadrant of the buttock.\n\n \n                  \n                     Subcutaneous administration is not advisable because of local irritation.",
    "warningsAndPrecautions_original": "Prochlorperazine Edisylate Injection, USP 5 mg/mL\n                  2 mL (10 mg) vial, packaged in 10's ( \n  NDC14789-700-02)",
    "adverseReactions_original": "Do not use in patients with known hypersensitivity to phenothiazines.\n                  Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc.).\n                  Do not use in pediatric surgery.\n                  Do not use in pediatric patients under 2 years of age or under 20 lbs. Do not use in children for conditions for which dosage has not been established."
}